GlassScriptPhysician profile
Amy Pelfrey
NPI 1609277151
$1,293.62
in general payments reported to CMS, 2019-2025
21 companies · $244 in 2025
The $244 reported for 2025 was more than what 80% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $386 · 2022: $151 · 2023: $251 · 2024: $260 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $263.33 | 2021-2022 | |
| Abbvie INC. | $190.88 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $134.89 | 2023-2025 | Farxiga, Airsupra |
| Lilly USA, LLC | $124.37 | 2022-2025 | Mounjaro, Trulicity |
| Glaxosmithkline, LLC. | $112.93 | 2021-2025 | Trelegy Ellipta, Bexsero, Shingrix |
| Novo Nordisk INC | $59.21 | 2023 | Ozempic, Rybelsus, Tresiba |
| Amgen INC. | $55.75 | 2023-2025 | Repatha, Otezla, Otezla |
| Takeda Pharmaceuticals U.S.A., INC. | $49.62 | 2021 | |
| Lifescan, INC. | $43.98 | 2021 | |
| Viiv Healthcare Company | $35.97 | 2023-2025 | Dovato |
| Hologic Sales and Service, LLC | $35.01 | 2025 | Aptima |
| Pfizer INC. | $31.21 | 2025 | |
| Gilead Sciences, INC. | $28.60 | 2024 | |
| Ironshore Pharmaceuticals INC. | $21.42 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $20.22 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $18.22 | 2021 | |
| Seqirus USA INC | $15.89 | 2025 | Fluad, Flucelvax |
| Biogen, INC. | $13.72 | 2024 | Zurzuvae |
| Cranial Technologies, INC | $13.43 | 2022 | |
| Organon LLC | $13.29 | 2021 | |
| Merck Sharp & Dohme LLC | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Pelfrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.